Director Heng Fai Ambrose Chan resigns; Jason T. Grady appointed to board

IMPACT BIOMEDICAL INC.

Heng Fai Ambrose Chan resigned as director effective June 6, 2024, with no disagreement.
Board appointed Jason T. Grady as director effective June 6, 2024.
Grady is COO of DSS, Inc., President of Premier Packaging, President/COO of DSS Wealth Management and BioLife Science.
No arrangement or understanding regarding Grady's appointment; no family relationship or related party transaction.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jason T. Grady

Director

IBO · IMPACT BIOMEDICAL INC.

Effective: 2024-06-06
Filed: June 7, 2024, 7:59 PM ET

Additionally on June 6, 2024, the Board of Directors of the Company appointed Jason T. Grady to serve as a Director of the Company, effective as of the same date.

Departed

Heng Fai Ambrose Chan

Director

IBO · IMPACT BIOMEDICAL INC.

Effective: 2024-06-06
Filed: June 7, 2024, 7:59 PM ET

On June 6, 2024, Heng Fai Ambrose Chan notified Impact Biomedical, Inc. (the “Company”) that he is resigning as a member of the Board of Directors of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jason T. Grady was appointed as Director at IMPACT BIOMEDICAL INC..

Action: appointed
Role: Director

Exact text from the filing

Additionally on June 6, 2024, the Board of Directors of the Company appointed Jason T. Grady to serve as a Director of the Company, effective as of the same date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Heng Fai Ambrose Chan resigned as Director at IMPACT BIOMEDICAL INC..

Action: resigned
Role: Director

Exact text from the filing

On June 6, 2024, Heng Fai Ambrose Chan notified Impact Biomedical, Inc. (the “Company”) that he is resigning as a member of the Board of Directors of the Company, effective immediately.

View on SEC.gov

IMPACT BIOMEDICAL INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-023096

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.